Abstract
We examined the effect of rosiglitazone on insulin sensitivity, abdominal fat and mid-thigh intramuscular fat distribution, and plasma concentrations of adipocytokines in patients with Type 2 diabetes. Rosiglitazone was administered at a daily dose of 4 mg to 42 Type 2 diabetes patients [age 32-70 years, body mass index (BMI) 17.5-32.6 kg/m(2), 15 women, 27 men] for 12 weeks. Various anthropometric and metabolic profiles, plasma adiponectin, leptin, and resistin levels were measured, and insulin resistance was calculated from the short insulin tolerance test. Body fat composition was assessed by computed tomography. Twelve weeks' rosiglitazone treatment resulted in improved insulin resistance despite increases in body weight and BMI. There was a significant decrease in abdominal visceral adipose tissue area (145 +/- 65.6 vs. 129 +/- 73.1 cm(2), P = 0.049). Mid-thigh low-density muscle area (TLDMA) increased from 23 +/- 9.6 to 26 +/- 8.2 cm(2) (P = 0.009). There were significant changes in plasma adipocytokines, but they were not significantly correlated with changes in insulin resistance. Rosiglitazone treatment resulted in an improvement of insulin responsiveness in Type 2 diabetic subjects, which was associated with the redis...Continue Reading
References
Feb 1, 1989·The Journal of Clinical Endocrinology and Metabolism·E BonoraM Muggeo
Jan 1, 1993·Science·G S HotamisligilB M Spiegelman
May 1, 1994·Clinical Endocrinology·S V GeldingD G Johnston
Sep 1, 1996·Diabetes·J J NolanJ F Caro
Jan 8, 1998·British Journal of Pharmacology·Q WangG Williams
Sep 4, 1998·Diabetes Care·H ShimizuM Mori
Apr 2, 1999·Diabetes·B H GoodpasterF L Thaete
Jun 18, 1999·Diabetes Care·Y MoriY Ikeda
Jul 30, 1999·Diabetes·G PerseghinL Luzi
Sep 15, 1999·Nature·I ShimomuraJ L Goldstein
Sep 24, 1999·Diabetologia·N G ForouhiJ D Bell
Apr 18, 2000·Diabetologia·M LoviscachR R Henry
Jul 25, 2000·Journal of Applied Physiology·B H GoodpasterR Ross
Jul 25, 2000·Diabetes·K F PetersenG I Shulman
Nov 22, 2000·The Journal of Clinical Investigation·L ChaoM L Reitman
Dec 6, 2000·The Journal of Clinical Investigation·C R KahnS E Cohen
Feb 24, 2001·Nature·C M SteppanM A Lazar
Jul 27, 2001·Diabetes·C J de SouzaB F Burkey
Aug 2, 2001·Nature Medicine·T YamauchiT Kadowaki
Mar 2, 2002·Diabetes·Adam B MayersonKitt F Petersen
May 15, 2002·The Journal of Biological Chemistry·Chunli YuGerald I Shulman
Sep 17, 2002·The American Journal of Cardiology·Kitt F Petersen, Gerald I Shulman
May 27, 2003·Diabetes Care·Dolmi KimKapbum Huh
Aug 5, 2003·Metabolism: Clinical and Experimental·Martin MuurlingPeter J Voshol
Jan 13, 2004·The Journal of Clinical Endocrinology and Metabolism·Byung-Soo YounKyong Soo Park
Jan 6, 2005·American Journal of Physiology. Endocrinology and Metabolism·Neda RasouliPhilip A Kern
Jun 18, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·R Mukhtar, J P D Reckless
Dec 6, 2006·The New England Journal of Medicine·Steven E KahnUNKNOWN ADOPT Study Group
Feb 9, 2007·European Journal of Endocrinology·A MajuriL Morin-Papunen
May 8, 2007·Atherosclerosis·E Louise ThomasRossi P Naoumova
Citations
Jun 12, 2012·Journal of Lipid Research·Janice V HuangGregory G Schwartz
Aug 21, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Si-Zeng Chen, Jian-Dong Xiao
Jul 1, 2014·Nutrition·Katja TrobecJochen Springer
May 25, 2013·Diabetes Care·UNKNOWN TODAY Study Group
Feb 22, 2012·Diabetes Care·Rachel GolanIris Shai
Sep 20, 2017·Methods of Information in Medicine·Haitham Abaza, Michael Marschollek
Oct 12, 2011·Current Opinion in Supportive and Palliative Care·Alisdair J MacDonaldVickie Baracos
Mar 20, 2012·The Journal of the Acoustical Society of America·Vikramjit MitraLouis Goldstein
Jun 1, 2017·Journal of Obesity & Metabolic Syndrome·Ki Dong KoKyu Rae Lee
Apr 10, 2019·American Journal of Physiology. Endocrinology and Metabolism·Marjorie BastienMarie-Eve Piché
Apr 21, 2019·Journal of Diabetes and Its Complications·Mohammed E Al-SofianiRita R Kalyani